首页> 美国卫生研究院文献>British Journal of Cancer >Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

【2h】

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

机译：雄激素受体和FOXA1共表达在非转移性三阴性乳腺癌中的预后价值及其与其他生物标志物的相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background In luminal androgen receptor (AR) tumours, FOXA1 may direct AR to sites occupied by ER in luminal tumours, thus stimulating proliferation.

机译：背景技术在管腔雄激素受体（AR）肿瘤中，FOXA1可能将AR引导至管腔肿瘤中ER占据的位点，从而刺激增殖。

著录项

期刊名称 British Journal of Cancer
作者
Séverine Guiu; Caroline Mollevi; Céline Charon-Barra; Florence Boissière; Evelyne Crapez; Elodie Chartron; Pierre-Jean Lamy; Marian Gutowski; Céline Bourgier; Gilles Romieu; Joelle Simony-Lafontaine; William Jacot;
展开▼
作者单位

展开▼
年(卷),期 2018(119),1
年度 2018
页码 76–79
总页数 4
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic value of androgen receptor and cathepsin D co-expression in non-metastatic triple-negative breast cancer and correlation with other biomarkers [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：雄激素受体和组织蛋白酶D共表达在非转移性三重阴性乳腺癌中的预后价值及与其他生物标志物的相关性
2. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer [J] . Tetsuyo Maeda, Yoko Nakanishi, Yukari Hirotani, Medical Molecular Morphology . 2016,第1期

机译：细胞角蛋白5/6，雄激素受体和p53的免疫组织化学共表达状态是三阴性乳腺癌辅助化疗的预后因素
3. Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al [J] . Breast Cancer: Targets and Therapy . 2016,第1期

机译：雄激素受体表达在三阴性乳腺癌中的预后价值：个人经验和Collignon等人对“三阴性乳腺癌：治疗挑战和解决方案”的评论
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. A TGFβ-Androgen Receptor Signaling Axis Affects Anoikis Resistance in Triple Negative Breast Cancer [D] . ?Rosas, Emmanuel 2020

机译：一个 TGFβ- 雄激素受体信号轴影响抗失巢凋亡在三阴性乳腺癌
6. Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about Triple-negative breast cancer: treatment challenges and solutions by Collignon et al [O] . Antonio Ieni, Valeria Barresi, Giuseppina Rosaria Rita Ricciardi, 2016

机译：雄激素受体表达在三阴性乳腺癌中的预后价值：个人经验和Collignon等对三阴性乳腺癌：治疗挑战和解决方案的评论
7. Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about ldquo;Triple-negative breast cancer: treatment challenges and solutionsrdquo; by Collignon et al [O] . Giovanni Tuccari, Antonio Ieni, Valeria Barresi, 2016

机译：三重阴性乳腺癌中雄激素受体表达的预后价值：个人经验和关于“三重阴性乳腺癌：治疗挑战和解决方案”的评论，Collignon等

Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

摘要

著录项

相似文献

相关主题

期刊订阅